Rotating the injection site is recommended to reduce the risk of tissue damage
Published laboratory work has studied GHK-Cu and BPC-157 in tissue and cellular models, examined KPV as a C-terminal alpha-MSH fragment in in-vitro work relating to inflammatory signalling pathways, and studied TB-500 in cell-based models
Some big employers have dropped coverage of the drugs due to the expense
Jamie DePolo: Okay, and I realize this is just the beginning, and you may not be able to answer this, but I'm wondering, from what I've read, when people take a GLP-1, either for diabetes or to lose weight, they're pretty much on it indefinitely because when they stop, they tend to gain some or all of the weight back
Find out how we test and monitor our patients gut microbiomes here